Approval and regulation
Before being marketed, all phytopharmaceutical
products must be assessed by the relevant authorities in the
countries concerned. In Europe, directive 91/414/CE sets out
the conditions that an active substance or phytopharmaceutical
product must satisfy in order to be approved.
Agriphar’s “approval” department is responsible for collating
studies into a dossier for assessment by the relevant authorities.
The sections of the dossier that concern the physical and chemical
properties of the product and analysis methods are mainly the
responsibility of the laboratory. A significant portion of the
dossier is also dedicated to the human health risk assessment

|